Abstract
Purpose
To describe the evolution of the current technique in percutaneous nephrolithotomy (PCNL) with a special focus on access tract closure techniques.
Methods
A systematic review of outcomes and complications of tubeless PCNL was conducted using the MEDLINE and Pubmed databases between 1976 and 2014.
Results
During the past decade, PCNL underwent fundamental modifications due to miniaturization of the instruments and advancements in technique. The routine use of the nephrostomy tube after PCNL has been subsequently questioned. Currently, the nephrostomy tube is increasingly omitted, and the access tract is usually sealed by haemostatic agents. An additionally ureteric stent is commonly inserted at the end of the procedure. However, the application of haemostatic sealants increases the immediate costs significantly. Still there are inconsistent data because of small study populations, lack of randomization, retrospective character and further more heterogeneous surgical techniques.
Conclusion
The current body of literature does not provide high-level evidence for the preferred treatment of the access tract in PCNL. However, most authors agree that a tract sealing can be omitted without increasing the risk of complication in uncomplicated procedures.
Similar content being viewed by others
Abbreviations
- DTPA:
-
Tc 99m technetium diethylenetriaminepentacetic acid
- NSD:
-
No significant difference
- PCNL:
-
Percutaneous nephrolithotomy
- POD:
-
Postoperative day
- SWL:
-
Shock wave therapy
- URS:
-
Ureterorenoscopy
References
Fernström I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10(3):257–259
Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2013) Guidelines on urolithiasis. http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR.pdf. Accessed 4 Feb 2015
Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW (1998) The “mini-perc” technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol 16(6):371–374
Bellman GC, Davidoff R, Candela J, Gerspach J, Kurtz S, Stout L (1997) Tubeless percutaneous renal surgery. J Urol 157(5):1578–1582
Zhong Q, Zheng C, Mo J, Piao Y, Zhou Y, Jiang Q (2013) Total tubeless versus standard percutaneous nephrolithotomy: a meta-analysis. J Endourol 27(4):420–426. doi:10.1089/end.2012.0421
Mikhail AA, Kaptein JS, Bellman GC (2003) Use of fibrin glue in percutaneous nephrolithotomy. Urology 61(5):910–914 (discussion 914)
Uribe CA, Eichel L, Khonsari S, Finley DS, Basillote J, Park HK, Li CC, Abdelshehid C, Lee DI, McDougall EM, Clayman RV (2005) What happens to hemostatic agents in contact with urine? An in vitro study. J Endourol 19(3):312–317. doi:10.1089/end.2005.19.312
Kim IY, Eichel L, Edwards R, Uribe C, Chou DS, Abdelshehid C, Ahlering M, White S, Woo E, McDougall E, Clayman RV (2007) Effects of commonly used hemostatic agents on the porcine collecting system. J Endourol 21(6):652–654. doi:10.1089/end.2007.9960
Lipkin ME, Mancini JG, Simmons WN, Raymundo ME, Yong DZ, Wang AJ, Ferrandino MN, Albala DM, Preminger GM (2011) Pathologic evaluation of hemostatic agents in percutaneous nephrolithotomy tracts in a porcine model. J Endourol 25(8):1353–1357. doi:10.1089/end.2011.0041
Yuan H, Zheng S, Liu L, Han P, Wang J, Wei Q (2011) The efficacy and safety of tubeless percutaneous nephrolithotomy: a systematic review and meta-analysis. Urol Res 39(5):401–410. doi:10.1007/s00240-010-0355-5
Zilberman DE, Lipkin ME, La Rosette JJd, Ferrandino MN, Mamoulakis C, Laguna MP, Preminger GM (2010) Tubeless percutaneous nephrolithotomy—the new standard of care? J Urol 184(4):1261–1266. doi:10.1016/j.juro.2010.06.020
Karami H, Gholamrezaie HR (2004) Totally tubeless percutaneous nephrolithotomy in selected patients. J Endourol 18(5):475–476. doi:10.1089/0892779041271580
Aghamir SM, Hosseini SR, Gooran S (2004) Totally tubeless percutaneous nephrolithotomy. J Endourol 18(7):647–648
Aghamir SM, Modaresi SS, Aloosh M, Tajik A (2011) Totally tubeless percutaneous nephrolithotomy for upper pole renal stone using subcostal access. J Endourol 25(4):583–586. doi:10.1089/end.2010.0064
Istanbulluoglu MO, Ozturk B, Gonen M, Cicek T, Ozkardes H (2009) Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. Int Urol Nephrol 41(3):541–545. doi:10.1007/s11255-008-9517-6
Crook TJ, Lockyer CR, Keoghane SR, Walmsley BH (2008) A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomy. J Urol 180(2):612–614. doi:10.1016/j.juro.2008.04.020
Chang CH, Wang CJ, Huang SW (2011) Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study. Urol Res 39(6):459–465. doi:10.1007/s00240-011-0363-0
Ozturk A, Guven S, Kilinc M, Topbas E, Piskin M, Arslan M (2010) Totally tubeless percutaneous nephrolithotomy: is it safe and effective in preschool children? J Endourol 24(12):1935–1939. doi:10.1089/end.2010.0100
Aghamir SM, Salavati A, Aloosh M, Farahmand H, Meysamie A, Pourmand G (2012) Feasibility of totally tubeless percutaneous nephrolithotomy under the age of 14 years: a randomized clinical trial. J Endourol 26(6):621–624. doi:10.1089/end.2011.0547
Kara C, Resorlu B, Bayindir M, Unsal A (2010) A randomized comparison of totally tubeless and standard percutaneous nephrolithotomy in elderly patients. Urology 76(2):289–293. doi:10.1016/j.urology.2009.11.077
Choe CH, L’Esperance JO, Auge BK (2009) The use of adjunctive hemostatic agents for tubeless percutaneous nephrolithotomy. J Endourol 23(10):1733–1738. doi:10.1089/end.2009.1543
Aghamir SMK, Khazaeli MH, Meisami A (2006) Use of Surgicel for sealing nephrostomy tract after totally tubeless percutaneous nephrolithotomy. J Endourol 20(5):293–295. doi:10.1089/end.2006.20.293
Li R, Louie MK, Lee HJ, Osann K, Pick DL, Santos R, McDougall EM, Clayman RV (2011) Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy. BJU Int 107(10):1660–1665. doi:10.1111/j.1464-410X.2010.09676.x
Shah HN, Hegde S, Shah JN, Mohile PD, Yuvaraja TB, Bansal MB (2006) A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy. J Urol 176(6 Pt 1):2488–2492. doi:10.1016/j.juro.2006.07.148 (discussion 2492–2483)
Singh I, Saran RN, Jain M (2008) Does sealing of the tract with absorbable gelatin (Spongostan) facilitate tubeless PCNL? A prospective study. J Endourol 22(11):2485–2493. doi:10.1089/end.2008.0321
Yu C, Xu Z, Long W, Longfei L, Feng Z, Lin Q, Xiongbing Z, Hequn C (2014) Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis. Urolithiasis 42(5):445–453. doi:10.1007/s00240-014-0687-7
Giusti G, Piccinelli A, Maugeri O, Graziotti P Is sealing of percutaneous tract with hemostatic sealant really necessary after tubeless procedure? J Urol 181(4):624. doi:10.1016/S0022-5347(09)61752-3
Giusti G, Piccinelli A, Maugeri O, Graziotti P (2009) Is sealing of percutaneous tract with hemostatic sealant really necessary after tubeless procedure? J Urol 181(4 Suppl):624. doi:10.1016/S0022-5347(09)61752-3
Istanbulluoglu MO, Kaynar M, Cicek T, Kosan M, Ozturk B, Ozkardes H (2013) A new hemostatic agent (Ankaferd Blood Stopper((R))) in tubeless percutaneous nephrolithotomy: a prospective randomized study. J Endourol 27(9):1126–1130. doi:10.1089/end.2013.0086
Shah HN, Kausik V, Hedge S, Shah JN, Bansal MB (2006) Initial experience with hemostatic fibrin glue as adjuvant during tubeless percutaneous nephrolithotomy. J Endourol 20(3):194–198. doi:10.1089/end.2006.20.194
Wang J, Zhang C, Tan G, Yang B, Chen W, Tan D (2014) The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis. Urolithiasis 42(6):509–517. doi:10.1007/s00240-014-0717-5
Ziaee SA, Sarhangnejad R, Abolghasemi H, Eshghi P, Radfar MH, Ahanian A, Kardoust Parizi M, Amirizadeh N, Nouralizadeh A (2013) Autologous fibrin sealant in tubeless percutaneous nephrolithotomy: a prospective study. Urology journal 10(3):999–1003
Rigopoulos C, Kyriazis I, Kallidonis P, Kalogeropoulou C, Koumoundourou D, Georgiopoulos I, Petsas T, Karnabatidis D, Constantinides C, Liatsikos E (2013) Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study. BJU Int 112(2):E114–E121. doi:10.1111/bju.12060
Schilling D, Winter B, Merseburger AS, Anastasiadis AG, Walcher U, Stenzl A, Nagele U (2008) Use of a gelatine–thrombin matrix for closure of the access tract without a nephrostomy tube in minimally invasive percutaneous nephrolitholapaxy. Urologe A 47(5):601–607. doi:10.1007/s00120-008-1673-x
Conflict of interest
None of the authors has any conflicting interest concerning the contents of this text.
Author information
Authors and Affiliations
Corresponding author
Additional information
Thomas R. W. Herrmann and David Schilling: for the Training and Research in Urologic Surgery and Technology (T.R.U.S.T.) Group.
Rights and permissions
About this article
Cite this article
Hüsch, T., Reiter, M., Mager, R. et al. The management of the access tract after percutaneous nephrolithotomy. World J Urol 33, 1921–1928 (2015). https://doi.org/10.1007/s00345-015-1558-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1558-8